What companies are BNTX's competitors?

BioNTech SE (BNTX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does BNTX compare to its peers?

The peer comparison table on this page shows BioNTech SE (BNTX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does BNTX operate in?

BioNTech SE (BNTX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

BNTX

BioNTech SE

NASDAQ·Biotechnology · Healthcare

$88.12$1.56−1.73%

After hours·$88.40+0.32%

Market cap$22.11B·Market closed·Oct 23 4:00 PM EDT

Frequently Asked Questions About BNTX

What companies are BNTX's competitors?: BioNTech SE (BNTX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does BNTX compare to its peers?: The peer comparison table on this page shows BioNTech SE (BNTX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does BNTX operate in?: BioNTech SE (BNTX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

BNTX

BioNTech SE

NASDAQ·Biotechnology · Healthcare

$88.12$1.56−1.73%

After hours·$88.40+0.32%

Market cap$22.11B·Market closed·Oct 23 4:00 PM EDT

Peers

Sort:


GMABGMABGenmab A/S	Genmab A/S	$43.79	$26.9B
INCYINCYIncyte Corporation	Incyte Corporation	$115.71	$23.5B
IBRXIBRXImmunityBio, Inc.	ImmunityBio, Inc.	$8.22	$8.7B
TGTXTGTXTG Therapeutics, Inc.	TG Therapeutics, Inc.	$54.17	$8.3B
IOVAIOVAIovance Biotherapeutics, Inc.	Iovance Biotherapeutics, Inc.	$14.09	$6.4B
XNCRXNCRXencor, Inc.	Xencor, Inc.	$25.84	$1.9B
IMCRIMCRImmunocore Holdings plc	Immunocore Holdings plc	$30.98	$1.6B
IMTXIMTXImmatics N.V.	Immatics N.V.	$7.31	$1.1B
CGENCGENCompugen Ltd.	Compugen Ltd.	$1.94	$183.8M
MGNXMGNXMacroGenics, Inc.	MacroGenics, Inc.	$2.25	$143.3M

Frequently Asked Questions About BNTX

What companies are BNTX's competitors?: BioNTech SE (BNTX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does BNTX compare to its peers?: The peer comparison table on this page shows BioNTech SE (BNTX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does BNTX operate in?: BioNTech SE (BNTX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.